Cargando…
Comparison of Novel Oral Anticoagulants and Vitamin K Antagonists in Patients With Cerebral Venous Sinus Thrombosis on Efficacy and Safety: A Systematic Review
Vitamin K antagonists (VKAs) are guideline-suggested subacute anticoagulants for cerebral venous sinus thrombosis (CVST), although there is potential hemorrhage risk in clinical use. In the last decade, novel oral anticoagulants (NOACs) have been applied as an alternative to VKAs in some kinds of th...
Autores principales: | Li, Hongjie, Yao, Meiling, Liao, Songjie, Chen, Jingyan, Yu, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758340/ https://www.ncbi.nlm.nih.gov/pubmed/33362699 http://dx.doi.org/10.3389/fneur.2020.597623 |
Ejemplares similares
-
Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review
por: Bose, Gauruv, et al.
Publicado: (2021) -
Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
por: Park, Joong Hyun, et al.
Publicado: (2018) -
Role of Decompressive Craniectomy in the Management of Cerebral Venous Sinus Thrombosis
por: Avanali, Raghunath, et al.
Publicado: (2019) -
Cerebral Venous Sinus Thrombosis in COVID-19: An Unusual Presentation
por: Kaur, Ikwinder, et al.
Publicado: (2021) -
Direct oral anticoagulants for the treatment of cerebral venous thrombosis – a protocol of an international phase IV study
por: van de Munckhof, Anita, et al.
Publicado: (2023)